Holen Sie sich die Stockscreener-App
3.95
1.41%
0.05
Clene Inc Aktie (CLNN) Neueste Nachrichten
Best Nanotechnology Stocks To Add to Your WatchlistJune 16th - MarketBeat
Clene Regains Nasdaq Compliance as of June 2025 - TipRanks
Top Nanotechnology Stocks Worth WatchingJune 17th - MarketBeat
Best Nanotechnology Stocks To Keep An Eye OnJune 15th - MarketBeat
Nanotechnology Stocks To Watch NowJune 14th - MarketBeat
Best Nanotechnology Stocks To Follow Now – June 13th - Defense World
Best Nanotechnology Stocks To Follow NowJune 13th - MarketBeat
Clene Inc. (NASDAQ:CLNN) Receives $40.00 Average Target Price from Analysts - Defense World
Promising Nanotechnology Stocks To ResearchJune 11th - MarketBeat
Nanotechnology Stocks To ResearchJune 8th - MarketBeat
Clene (NASDAQ:CLNN) Trading Down 0.7% – Should You Sell? - Defense World
Clene Inc. CEO to Share Company Updates at Investor Summit Virtual - citybuzz -
Clene Inc. Chief Executive Officer Rob Etherington to Present at - GuruFocus
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 | CLNN Stock News - GuruFocus
Clene CEO Rob Etherington Set to Reveal Company Updates at Investor Summit Virtual Conference - Stock Titan
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 - The Globe and Mail
Nanotechnology Stocks To Follow NowJune 9th - MarketBeat
Clene Inc. (CLNN) Executives to Host Meeting with Maxim | CLNN S - GuruFocus
Clene management to meet with Maxim - TipRanks
Nanomedicines Market Booming Worldwide: Growth Trends, - openPR.com
Clene Inc. shareholder General Resonance sells $2,472 in stock - Investing.com
Best Nanotechnology Stocks To Follow Today – May 31st - Defense World
Clene Inc. shareholder General Resonance sells $2,472 in stock By Investing.com - Investing.com UK
Clene Inc.: General Resonance LLC sells $1,148 in common stock By Investing.com - Investing.com Nigeria
Clene Inc.: General Resonance LLC sells $1,148 in common stock - Investing.com
Clene inc. sees $1,089 stock sale by major shareholder - Investing.com South Africa
Clene Approves Stock Plan Amendment at Annual Meeting - TipRanks
Clene stock touches 52-week low at $2.5 amid market challenges By Investing.com - Investing.com South Africa
Clene stock touches 52-week low at $2.5 amid market challenges - Investing.com Australia
Brokerages Set Clene Inc. (NASDAQ:CLNN) Target Price at $40.00 - Defense World
Clene eyeing regulatory submission for CNM-Au8 in ALS by year’s end - ALS News Today
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates - MSN
HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World
Roth Capital Has Optimistic Outlook of Clene Q2 Earnings - Defense World
Benchmark Lowers Clene (NASDAQ:CLNN) Price Target to $33.00 - Defense World
D. Boral Capital Reaffirms Buy Rating for Clene (NASDAQ:CLNN) - Defense World
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures - TipRanks
Promising Nanotechnology Stocks To Watch Now – May 7th - The AM Reporter
Clene Inc. Advances CNM-Au8 Treatment for ALS, Reports Promising Q1 Results - citybuzz -
Clene Inc. Advances CNM-Au8 Toward Potential Accelerated Approval for ALS - citybuzz -
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating - TipRanks
Clene (CLNN) Maintains Buy Rating Despite Price Target Reduction | CLNN Stock News - GuruFocus
Clene (CLNN) Stock Rating and Price Target Maintained at Buy | C - GuruFocus
Renaissance Technologies LLC Invests $96,000 in Clene Inc. (NASDAQ:CLNN) - Defense World
Clene Inc. to Showcase Neurodegenerative Research at D. Boral Capital Global Conference - citybuzz -
Clene (CLNN) Reports Decline in Cash Reserves | CLNN Stock News - GuruFocus
Clene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits - TipRanks
Clene (CLNN) Exceeds Revenue Expectations and Advances ALS Research | CLNN Stock News - GuruFocus
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - The Manila Times
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference | CLNN Stock News - GuruFocus
Clene Inc. SEC 10-Q Report - TradingView
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
0.22%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):